Skip to content
  • Sunday, 26 July 2026
  • 2:51 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • J&J raises FY26 outlook following positive Q2 – Pharmaceutical Technology
Pharmaceutical R&D

J&J raises FY26 outlook following positive Q2 – Pharmaceutical Technology

Teuku Ryan Jul 16, 2026 0

Johnson & Johnson (J&J) announced robust second-quarter (Q2) revenues totaling approximately $25.3 billion, marking a significant 6.6% increase year-over-year (YoY).…

Read More
Clinical Diagnostics & Pathology

AI Lab Result Interpretation Gains Traction with Patients, but Raises Accuracy and Validation Concerns for Clinical Laboratories

Reynand Amr Wu May 27, 2026 0

The burgeoning landscape of digital health is undergoing a profound transformation as artificial intelligence (AI) begins to permeate even the…

Read More
Clinical Diagnostics & Pathology

AI Lab Result Interpretation Gains Traction with Patients, but Raises Accuracy and Validation Concerns for Clinical Laboratories

Reynand Amr Wu May 20, 2026 0

The landscape of healthcare is undergoing a profound transformation, driven by the accelerating integration of artificial intelligence (AI) into various…

Read More
Clinical Diagnostics & Pathology

AI Lab Result Interpretation Gains Traction with Patients, but Raises Accuracy and Validation Concerns for Clinical Laboratories

Reynand Amr Wu May 12, 2026 0

A burgeoning cohort of health-conscious consumers is increasingly bypassing traditional medical channels, opting instead to feed their raw laboratory data…

Read More
Clinical Diagnostics & Pathology

AI Lab Result Interpretation Gains Traction with Patients, but Raises Accuracy and Validation Concerns for Clinical Laboratories

Reynand Amr Wu May 5, 2026 0

The burgeoning integration of artificial intelligence into daily life is profoundly reshaping how individuals interact with complex medical information, particularly…

Read More
Laboratory Automation & Robotics

Medvi’s QUAD Erectile Dysfunction Cocktail Raises Significant Safety Concerns Amidst Regulatory Scrutiny and Questionable Marketing Practices

Lana Keisha May 2, 2026 0

The burgeoning telehealth industry, lauded for its potential to democratize healthcare access, is facing intensified scrutiny as companies push the…

Read More
Pharmaceutical R&D

Eli Lilly Soars Past Expectations on Unabated Weight-Loss Drug Demand, Raises Full-Year Forecast

Teuku Ryan May 2, 2026 0

Eli Lilly and Company has once again demonstrated its formidable market power, reporting first-quarter 2026 sales that significantly surpassed analyst…

Read More
Clinical Diagnostics & Pathology

AI Lab Result Interpretation Gains Traction with Patients, but Raises Accuracy and Validation Concerns for Clinical Laboratories

Reynand Amr Wu Apr 28, 2026 0

The landscape of patient engagement with their own health data is undergoing a profound transformation, driven by the rapid advancements…

Read More
Clinical Diagnostics & Pathology

AI Lab Result Interpretation Gains Traction with Patients, but Raises Accuracy and Validation Concerns for Clinical Laboratories

Reynand Amr Wu Apr 21, 2026 0

The landscape of patient engagement with their health data is undergoing a profound transformation, driven by the rapid advancement and…

Read More
Laboratory Automation & Robotics

Cellares Raises $257M Series D to Automate Cell Therapy Manufacturing

Lana Keisha Mar 24, 2026 0

The burgeoning field of cell and gene therapy, heralded as a revolutionary frontier in medicine, is currently grappling with a…

Read More
Drugs in the Bahamas’ waters and sharks’ bloodstreams reveal the extent of human pollutionCornell University Researchers Develop Breakthrough Reversible Nonhormonal Male Contraceptive Method Targeting MeiosisSeven Pharma Companies Selected for FDA PreCheck Pilot Program to Bolster U.S. Drug Supply ChainTWiV 1285: Encapsidating Viruses 2025
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ